OpenAlex
Synthesis and In Vitro Study of Antiviral Activity of Glycyrrhizin Nicotinate Derivatives against HIV-1 Pseudoviruses and SARS-CoV-2 Viruses
Work
Year: 2022
Type: article
Abstract: When developing drugs against SARS-CoV-2, it is important to consider the characteristics of patients with different co-morbidities. People infected with HIV-1 are a particularly vulnerable group, as ... more
Source: Molecules
Cites: 32
Cited by: 14
Related to: 10
FWCI: 3.39
Citation percentile (by year/subfield): 99.98
Subfield: Pharmacology
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,490